INOVIO PHARMACEUTI revenue for the last year amounted to 700.50 k CHF, the most of which — 700.50 k CHF — came from its highest performing source at the moment, DNA Medicines, the year earlier bringing 9.49 M CHF. The greatest contribution to the revenue figure was made by United States — last year it brought INOVIO PHARMACEUTI 700.50 k CHF, and the year before that — 9.49 M CHF.